Star Health Insurance settles claims of Rs.11,500 Cr
The company has improved access to quality healthcare for seniors across both urban and rural areas
The company has improved access to quality healthcare for seniors across both urban and rural areas
The company’s virgin PET chips plant in Egypt, commissioned in Q4 FY25, achieved 74.8 per cent capacity utilization in its first full quarter. In India, the Panipat facility operated at 96.6 per cent utilization
Rivaroxaban is used to treat venous thromboembolism
Aurobindo Pharma’s US formulations revenue slipped 1.9% on a year-on-year basis to Rs. 3,488 crore
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies
New platform powered by Opentrons expands lab automation to accelerate scientific discovery
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
Star Health Insurance is modernising its claims ecosystem to be future-ready
During the quarter, US formulations revenue increased by 13.5 per cent YoY to Rs. 4,072 crore
Subscribe To Our Newsletter & Stay Updated